Pharmaceutical market has enjoyed robust March, but now seriously prepared to drop in demand, eventually to the end of the year, even in the most optimistic scenario it is unlikely the dynamics of the retail segment will go beyond stagnation, analysts said RNC Pharma. Now consumption curve is noticeably lower than the standard seasonal performance – spent reserves made during the boom.
Legislative activity has also undergone a period of explosive activity. However, in respect of pharmaceutical legislative rush in the fight against the epidemic had one important result: intensified process of legalization of online trading of drugs.
The work of pharmaceutical companies at a time of crisis is not suspended, in fact, the pharmaceutical market has not suffered from outright bans related to the epidemic coronavirus infection. However, the crisis still affected the branch: a separate network suspended operation of a significant number of pharmacies has closed a number of outlets in shopping centers and airports. Previously it was a natural traffic generators, now even in sakassou areas of the shopping traffic dropped noticeably, as well as changed the list of sought-after assortment.
In the current situation among the classic pharmacy chains the first line of the rating took Rigla pharmacy with its 2905 points (volume of the market of 6.5%). On the second place in terms of companies “Erkafarm” (4,3%), and the third place – “Neofarma” (4,1%). On the fourth and fifth places, “pharmacy chain 36,6” (4,0%) and “Vita” (3,4%). Among the services of the remote ordering leader of the “Pharmacy.ru”, followed by “Zdraveite and Apteka”.